Integrate SmartSignals Data Analytics into Your Next Clinical Trial Date Published: Mar 05, 2021 Brochure Collect and compare data with Signant’s SmartSignals Data Analytics – you’ll be able to identify potential data risks early and take corrective measures to protect the endpoint quality. We aggregate data at various study levels and compare it to broader study data. This brochure details the differences between our full-service Blinded Data Analytics (BDA) and self-service Outcome Analytics. Signant’s Data Analytics verifies: Rater Reliability Participant eligibility Scoring consistency We provide six reasons you should choose Signant’s SmartSignals™ Data Analytics for your eCOA strategy. Download Now Share: LinkedInTweet Recommended Resources Electronic Clinician Ratings Solution Download Now Brochure Article Optimal COA Measurement Strategy in Modern Oncology Trials The inclusion of patient-reported outcomes (PRO) data in oncology medication labeling in the U.S. has been comparatively limited. Recent FDA... Read Now 3 Themes and Takeaways From FDA’s Draft Guidance on DCTs Download Now Whitepaper